Catalyst Wire Dossier Catalyst Wire Dossier

MK0653A

· Organon and Co
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for MK0653A, covering 2024-05-10 to 2024-08-15. Get the full timeline:

Most recent: Clinical Trial Update: Cholesterol Lowering Level of MK0653A+Simvastatin in Patients With Hypercholesterolemia and Atherosclerotic or Coronary Vascular Disease (0653A-806)(COMPLETED) [Phase 3]

See pricing